Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Among authors: murai h. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C; CSPS 2 group. Shinohara Y, et al. Lancet Neurol. 2010 Oct;9(10):959-68. doi: 10.1016/S1474-4422(10)70198-8. Epub 2010 Sep 15. Lancet Neurol. 2010. PMID: 20833591 Clinical Trial.
Health-related quality-of-life and treatment targets in myasthenia gravis.
Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Murai H, Imai T, Tsuda E, Konno S, Nakane S, Suzuki Y, Fujihara K, Suzuki N. Utsugisawa K, et al. Among authors: murai h. Muscle Nerve. 2014 Oct;50(4):493-500. doi: 10.1002/mus.24213. Epub 2014 Aug 30. Muscle Nerve. 2014. PMID: 24536040
Quality of life in purely ocular myasthenia in Japan.
Suzuki S, Murai H, Imai T, Nagane Y, Masuda M, Tsuda E, Konno S, Oji S, Nakane S, Motomura M, Suzuki N, Utsugisawa K. Suzuki S, et al. Among authors: murai h. BMC Neurol. 2014 Jul 5;14:142. doi: 10.1186/1471-2377-14-142. BMC Neurol. 2014. PMID: 24996227 Free PMC article.
Oral corticosteroid therapy and present disease status in myasthenia gravis.
Imai T, Suzuki S, Tsuda E, Nagane Y, Murai H, Masuda M, Konno S, Suzuki Y, Nakane S, Fujihara K, Suzuki N, Utsugisawa K. Imai T, et al. Among authors: murai h. Muscle Nerve. 2015 May;51(5):692-6. doi: 10.1002/mus.24438. Epub 2015 Feb 4. Muscle Nerve. 2015. PMID: 25155615
Insights into the classification of myasthenia gravis.
Akaishi T, Yamaguchi T, Suzuki Y, Nagane Y, Suzuki S, Murai H, Imai T, Motomura M, Fujihara K, Aoki M, Utsugisawa K. Akaishi T, et al. Among authors: murai h. PLoS One. 2014 Sep 5;9(9):e106757. doi: 10.1371/journal.pone.0106757. eCollection 2014. PLoS One. 2014. PMID: 25192469 Free PMC article.
534 results